{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:23:10Z","timestamp":1793406190899,"version":"4.5.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>\nBackground\n<\/jats:title>\n<jats:p>After head and neck cancer surgery with free flap reconstruction, the use of glucocorticoids is often required to alleviate inflammation and edema. However, the impact of glucocorticoid on postoperative complications and cancer progression remains unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>\nMethods\n<\/jats:title>\n<jats:p>This retrospective cohort study included 711 elderly patients who underwent head and neck cancer surgery with free flap reconstruction at Shanghai Ninth People\u2019s Hospital from January 1, 2014, to December 31, 2022. Patients were categorized based on postoperative glucocorticoid usage into a high-dose steroid group (n\u2009=\u2009307) and a control group (n\u2009=\u2009404). The study focused on the impact of postoperative GC use on postoperative complications and long-term oncological outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>\nResults\n<\/jats:title>\n<jats:p>Multivariate analysis indicated that compared to the control group, the high-dose steroid group had a significant increase in postoperative complications, including atelectasis (OR: 3.83, 95% CI: 1.27\u201314.11, P\u2009=\u20090.025), postoperative hyperglycemia (OR: 1.54, 95% CI: 1.14\u20132.08, P\u2009=\u20090.006), and flap complications (OR: 4.61, 95% CI: 3.31\u20136.47, P\u2009&lt;\u20090.001). These complications often required extended hospital stays (\u03b2: 1.656, 95% CI: 1.075-2.236, P &lt;\u2009 0.001). Additionally, the high-dose steroid group had a higher rate of unplanned readmissions within one year (OR: 5.61, 95% CI: 3.87\u20138.25, P\u2009&lt; 0.001). The increased readmission rates were notably due to difficulties swallowing requiring percutaneous gastrostomy (OR: 3.62, 95% CI: 1.97\u20136.98, P\u2009&lt; 0.001), recurrence (OR: 9.34, 95% CI: 5.02\u201319.05, P\u2009&lt; 0.001), and metastasis (OR: 4.78, 95% CI: 2.58-9.44, P &lt; 0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>\nConclusion\n<\/jats:title>\n<jats:p>The use of high-dose postoperative glucocorticoids is associated with increased postoperative complications, higher readmission rates, and poorer oncological outcomes in patients. The results advocate for cautious use and dosage management of perioperative glucocorticoids in head and neck surgeries to optimize patient outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0319655","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:35:56Z","timestamp":1741714556000},"page":"e0319655","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of postoperative glucocorticoids on complications after head and neck cancer surgery with free flap reconstruction: A retrospective study"],"prefix":"10.1371","volume":"20","author":[{"given":"Tao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-7862","authenticated-orcid":true,"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"10318","key":"pone.0319655.ref001","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"398","author":"MD Mody","year":"2021","journal-title":"Lancet"},{"key":"pone.0319655.ref002","first-page":"491","article-title":"33 - The Molecular Pathogenesis of Head and Neck Cancer.","author":"ML Hedberg","year":"2015"},{"issue":"1","key":"pone.0319655.ref003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"DE Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"pone.0319655.ref004","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/jama.284.14.1761","article-title":"Microvascular free-flap reconstruction in the head and neck","volume":"284","author":"ND Futran","year":"2000","journal-title":"JAMA"},{"issue":"5","key":"pone.0319655.ref005","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1016\/S1470-2045(17)30252-8","article-title":"The future of personalised radiotherapy for head and neck cancer","volume":"18","author":"JJ Caudell","year":"2017","journal-title":"Lancet Oncol"},{"key":"pone.0319655.ref006","doi-asserted-by":"crossref","first-page":"114930","DOI":"10.1016\/j.bcp.2022.114930","article-title":"Glucocorticoids and natural killer cells: A suppressive relationship","volume":"198","author":"I Muscari","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"pone.0319655.ref007","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1470-2045(10)70166-2","article-title":"Does the existing standard of care increase glioblastoma energy metabolism?","volume":"11","author":"TN Seyfried","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"pone.0319655.ref008","first-page":"1295","article-title":"Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma","volume":"29","author":"C Zhang","year":"2006","journal-title":"Int J Oncol"},{"issue":"Pt 5","key":"pone.0319655.ref009","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/brain\/aww046","article-title":"Corticosteroids compromise survival in glioblastoma","volume":"139","author":"KL Pitter","year":"2016","journal-title":"Brain"},{"key":"pone.0319655.ref010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13014-015-0527-0","article-title":"Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients","volume":"10","author":"LBE Shields","year":"2015","journal-title":"Radiat Oncol"},{"issue":"6","key":"pone.0319655.ref011","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jcb.23081","article-title":"Keratinocytes synthesize and activate cortisol","volume":"112","author":"N Cirillo","year":"2011","journal-title":"J Cell Biochem"},{"issue":"7","key":"pone.0319655.ref012","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/bjc.2017.243","article-title":"Characterisation of the cancer-associated glucocorticoid system: key role of 11\u03b2-hydroxysteroid dehydrogenase type 2","volume":"117","author":"N Cirillo","year":"2017","journal-title":"Br J Cancer"},{"issue":"9","key":"pone.0319655.ref013","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41591-019-0566-4","article-title":"Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity","volume":"25","author":"H Yang","year":"2019","journal-title":"Nat Med"},{"issue":"10","key":"pone.0319655.ref014","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jclinpath-2012-200695","article-title":"Increased plasma and salivary cortisol levels in patients with oral cancer and their association with clinical stage","volume":"65","author":"DG Bernab\u00e9","year":"2012","journal-title":"J Clin Pathol"},{"key":"pone.0319655.ref015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2016.12.008","article-title":"Dexamethasone in head and neck cancer patients with microvascular reconstruction: No benefit, more complications","volume":"65","author":"S Kainulainen","year":"2017","journal-title":"Oral Oncol"},{"issue":"10","key":"pone.0319655.ref016","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.joms.2020.05.004","article-title":"Perioperative Dexamethasone Is Associated With Higher Short-Term Mortality in Reconstructive Head and Neck Cancer Surgery","volume":"78","author":"S Kainulainen","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"key":"pone.0319655.ref017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2018.02.009","article-title":"Hyperglycemia and risk of adverse outcomes following microvascular reconstruction of oncologic head and neck defects","volume":"79","author":"2nd Offodile AC","year":"2018","journal-title":"Oral Oncol"},{"issue":"6","key":"pone.0319655.ref018","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"ES Moghissi","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0319655.ref019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"D Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"7","key":"pone.0319655.ref020","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/hed.26689","article-title":"An improved predictive model for postoperative pulmonary complications after free flap reconstructions in the head and neck","volume":"43","author":"DK Smith","year":"2021","journal-title":"Head Neck"},{"issue":"1","key":"pone.0319655.ref021","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"JA Kellum","year":"2013","journal-title":"Crit Care"},{"issue":"6","key":"pone.0319655.ref022","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"AE Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"1","key":"pone.0319655.ref023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hed.2880140104","article-title":"Effect of advanced age and medical disease on the outcome of microvascular reconstruction for head and neck defects","volume":"14","author":"KC Shestak","year":"1992","journal-title":"Head Neck"},{"issue":"3","key":"pone.0319655.ref024","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jfma.2023.09.003","article-title":"Incidence and risk factors of postoperative pulmonary complications after oral cancer surgery with free flap reconstruction: A single center study","volume":"123","author":"C-J Lai","year":"2024","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"pone.0319655.ref025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijom.2020.06.011","article-title":"Postoperative pulmonary complications following major head and neck cancer surgery","volume":"50","author":"LM Shaw","year":"2021","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"pone.0319655.ref026","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/endrev\/bnad016","article-title":"Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?","volume":"44","author":"R Pofi","year":"2023","journal-title":"Endocr Rev"},{"issue":"11","key":"pone.0319655.ref027","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-04-0054","article-title":"Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck","volume":"10","author":"I Kuss","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"4","key":"pone.0319655.ref028","first-page":"422","article-title":"Steroid-induced myopathy","volume":"41","author":"S Perrot","year":"2012","journal-title":"Presse Med"},{"issue":"6 Pt 1","key":"pone.0319655.ref029","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1164\/ajrccm.153.6.8665061","article-title":"Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease","volume":"153","author":"M Decramer","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pone.0319655.ref030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/ijms22020623","article-title":"Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance","volume":"22","author":"C Beaupere","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"pone.0319655.ref031","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","article-title":"Corticosteroid-induced adverse events in adults: frequency, screening and prevention","volume":"30","author":"L Fardet","year":"2007","journal-title":"Drug Saf"},{"issue":"4","key":"pone.0319655.ref032","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/SLA.0b013e31818990d1","article-title":"Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery","volume":"248","author":"M Ramos","year":"2008","journal-title":"Ann Surg"},{"issue":"6","key":"pone.0319655.ref033","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.oooo.2014.02.033","article-title":"Effects of perioperatively administered dexamethasone on surgical wound healing in patients undergoing surgery for zygomatic fracture: a prospective study","volume":"117","author":"J Sn\u00e4ll","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"pone.0319655.ref034","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"DW Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"pone.0319655.ref035","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jmb.2004.11.027","article-title":"From an enhanceosome to a repressosome: molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing","volume":"345","author":"B Lee","year":"2005","journal-title":"J Mol Biol"},{"issue":"1","key":"pone.0319655.ref036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"D Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"pone.0319655.ref037","doi-asserted-by":"crossref","first-page":"1673635","DOI":"10.1080\/2162402X.2019.1673635","article-title":"Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies","volume":"9","author":"Y Ma","year":"2019","journal-title":"Oncoimmunology"},{"issue":"1","key":"pone.0319655.ref038","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41368-020-0084-8","article-title":"Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma","volume":"12","author":"Z Mei","year":"2020","journal-title":"Int J Oral Sci"},{"issue":"11","key":"pone.0319655.ref039","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/jcp.25408","article-title":"The Non-Conventional Effects of Glucocorticoids in Cancer","volume":"231","author":"S Azher","year":"2016","journal-title":"J Cell Physiol"},{"issue":"5","key":"pone.0319655.ref040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(06)70694-5","article-title":"Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases","volume":"7","author":"I Herr","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:36:12Z","timestamp":1741714572000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319655"}},"subtitle":[],"editor":[{"given":"John Minh","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319655","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}